Choledocholithiasis Clinical Trial
— VERTOfficial title:
Evaluate the Efficacy of ICG Fluorescent Cholangiography for Visualization of Extrahepatic Biliary Anatomy in Emergency Cholecystectomy: A Single-Center, Randomized, Controlled, Parallel-Group Study
This study is a prospective randomized controlled trial evaluating the use of a fluorescent dye, indocyanine green (ICG), in the identification of important bile duct anatomy during emergent same-admission cholecystectomy. Participants will be randomized into either the control arm, which uses the standard of care white light during laparoscopy or the intervention arm, which will use ICG fluorescent cholangiography as an adjunct to white light to visualize the biliary anatomy. The investigators hypothesize that the use of fluorescent cholangiography will increase the rates of identification of important biliary anatomy during laparoscopic cholecystectomy. The effectiveness, feasibility, and safety will be compared between the two groups using a post-operative survey form the surgeons will complete prior to exiting the operating room.
Status | Not yet recruiting |
Enrollment | 340 |
Est. completion date | January 2023 |
Est. primary completion date | December 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Admission or consultation by the Acute Care Surgery (ACS) service - Diagnosis of acute biliary disease requiring index laparoscopic cholecystectomy - Diagnoses of acute cholangitis, choledocholithiasis, and gall stone pancreatitis may be included. However, they must have cleared ducts confirmed via endoscopic ultrasound, ultrasound, ERCP, and/or laboratory investigations. - Ability to understand and follow study procedures and protocols, and provide signed informed consent. Exclusion Criteria: - Female patients who are pregnant or currently breastfeeding - Known pre-existing liver disease, including cirrhosis - Known allergy to iodine or shellfish - Known allergy to indocyanine green (ICG) |
Country | Name | City | State |
---|---|---|---|
Canada | Vancouver General Hospital | Vancouver | British Columbia |
Lead Sponsor | Collaborator |
---|---|
University of British Columbia |
Canada,
Bleszynski MS, DeGirolamo KM, Meneghetti AT, Chiu CJ, Panton ON. Fluorescent Cholangiography in Laparoscopic Cholecystectomy: An Updated Canadian Experience. Surg Innov. 2020 Feb;27(1):38-43. doi: 10.1177/1553350619885792. Epub 2019 Nov 19. — View Citation
Zroback C, Chow G, Meneghetti A, Warnock G, Meloche M, Chiu CJ, Panton ON. Fluorescent cholangiography in laparoscopic cholecystectomy: the initial Canadian experience. Am J Surg. 2016 May;211(5):933-7. doi: 10.1016/j.amjsurg.2016.01.013. Epub 2016 Feb 23. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Adverse events | Any adverse events associated with the administration or use of ICG fluorescent cholangiography | Through participant discharge, an average of 1 week | |
Other | Procedural complications | Any complications associated with the cholecystectomy | Through participant discharge, an average of 1 week | |
Primary | Detection rate of extrahepatic biliary structures | The extrahepatic biliary structures which we will be assessing the identification of include: Cystic Duct (CD), Right Hepatic Duct (RHD), Common Hepatic Duct (CHD), Common Bile Duct (CBD), Cystic Duct - Gall Bladder junction (CD-GB), and Cystic Duct - Common Bile Duct junction (CD-CBD). | Intraoperatively | |
Secondary | Operative success | Rates of laparoscopic subtotal cholecystectomy and laparoscopic cholecystostomy tube placement. | Intraoperatively | |
Secondary | Rates of conversion | Rate of conversion to open cholecystectomy. | Intraoperatively | |
Secondary | Operative time | From the time of opening the skin to the time of closure. | Intraoperatively | |
Secondary | Surgeon satisfaction | Operating surgeons satisfaction (as rated by post-procedural survey) with the utility and feasibility of the modality. | Through participant discharge, an average of 1 week |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03536247 -
Papillary Balloon Dilation Versus Intraductal Lithotripsy
|
N/A | |
Recruiting |
NCT05035433 -
Effect of the Sequence of Dilatation and Lithotripsy on the Treatment of Choledocholithiasis With ERCP
|
N/A | |
Not yet recruiting |
NCT06060002 -
Role of Prophylactic Biliary Stent in Reducing the Recurrence of Choledocholithiasis
|
N/A | |
Recruiting |
NCT06041113 -
Recurrent Extrahepatic Bile Duct Stones as a Late Complication of ERCP in Patients With Coexisting Intra- and Extrahepatic Bile Duct Stones
|
||
Completed |
NCT02461147 -
Prospective Validation of "Cholecystectomy First" Strategy for Gallstone Migration
|
||
Recruiting |
NCT00416234 -
Laparoendoscopic Rendez Vous Versus Standard Two Stage Approach for the Management of Cholelithiasis/Choledocholithiasis
|
N/A | |
Active, not recruiting |
NCT05592795 -
Explore the Effects and Mechanisms of ERCP and EST on Biliary Microecology
|
||
Recruiting |
NCT05056506 -
EPLBD With Limited EST vs. EPLBD for Choledocholithiasis
|
N/A | |
Completed |
NCT02515474 -
Comparison of LCBDE vs ERCP + LC for Choledocholithiasis
|
N/A | |
Recruiting |
NCT05429203 -
Comparison of Duodenoscope With Single-use Distal Cover and the Conventional Reusable Duodenoscope
|
N/A | |
Completed |
NCT01824186 -
Trial Comparing Pain in Single-incision Laparoscopic Cholecystectomy Versus Conventional Laparoscopic Cholecystectomy
|
N/A | |
Completed |
NCT02647593 -
The Clinical Characteristics of the Patients With Choledocholithiasis Without Cholangitis
|
||
Not yet recruiting |
NCT06066372 -
Application of Machine Learning Models to Reduce Need for Diagnostic EUS or MRCP in Patients With Intermediate Likelihood of Choledocholithiasis
|
||
Completed |
NCT04716166 -
Incentive Spirometry and Upper Abdominal Laparoscopic Surgery
|
N/A | |
Completed |
NCT03074201 -
Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP
|
N/A | |
Withdrawn |
NCT01475864 -
Prospective Evaluation of the Covered Self-expandable Metal Stents (CSEMS) for Incomplete Biliary Stone Clearance
|
N/A | |
Recruiting |
NCT06265311 -
IDUS in CBD Stone Recurrence High Risk Patients
|
N/A | |
Completed |
NCT02870686 -
EUS Guided ERCP in Bile Duct Stone Removal
|
N/A | |
Recruiting |
NCT05611840 -
RCT on Robotic vs. Endo-laparoscopic Approach for Difficult Choledocholithiasis
|
N/A | |
Recruiting |
NCT03102281 -
Microbiomes in Patients of Recurrent Common Bile Duct Stones
|
N/A |